A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone
L. Wang, S. M. Dehm, D. W. Hillman, H. Sicotte, W. Tan, M. Gormley, V. Bhargava, R. Jimenez, F. Xie, P. Yin, S. Qin, F. Quevedo, B. A. Costello, H. C. Pitot, T. Ho, A. H. Bryce, Z. Ye, Y. Li, P. Eiken, P. T. VedellP. Barman, B. P. McMenomy, T. D. Atwell, R. E. Carlson, M. Ellingson, B. W. Eckloff, R. Qin, F. Ou, S. N. Hart, H. Huang, J. Jen, E. D. Wieben, K. R. Kalari, R. M. Weinshilboum, L. Wang, M. Kohli
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone'. Together they form a unique fingerprint.